The stock of Vivos Therapeutics Inc (NASDAQ:VVOS) last traded at $0.33, up 6.90% from the previous session.
Data from the available sources indicates that Vivos Therapeutics Inc (NASDAQ:VVOS) is covered by 2 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $2.90 and a low of $0.70, we find $1.80. Given the previous closing price of $0.30, this indicates a potential upside of 500.0 percent. VVOS stock price is now 22.23% away from the 50-day moving average and -36.58% away from the 200-day moving average. The market capitalization of the company currently stands at $9.74M.
In total, 0 analysts have assigned it a hold rating, and 2 have given it a buy rating. Brokers who have rated the stock have averaged $1.80 as their price target over the next twelve months.
In other news, Huntsman Ronald Kirk, Chief Executive Officer bought 14,000 shares of the company’s stock on Jun 20. The stock was bought for $7,420 at an average price of $0.53. Upon completion of the transaction, the Chief Executive Officer now directly owns 86,521 shares in the company, valued at $28551.93. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 16, Chief Executive Officer Huntsman Ronald Kirk bought 15,000 shares of the business’s stock. A total of $8,050 was incurred on buying the stock at an average price of $0.54. This leaves the insider owning 72,521 shares of the company worth $23931.93. A total of 16.80% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in VVOS stock. A new stake in Vivos Therapeutics Inc shares was purchased by LPL FINANCIAL LLC during the first quarter worth $12,000. SIGNATUREFD, LLC invested $4,000 in shares of VVOS during the first quarter. In the first quarter, TWO SIGMA SECURITIES, LLC acquired a new stake in Vivos Therapeutics Inc valued at approximately $4,000. In total, there are 30 active investors with 15.68% ownership of the company’s stock.
With an opening price of $0.3521 on Thursday morning, Vivos Therapeutics Inc (NASDAQ: VVOS) set off the trading day. During the past 12 months, Vivos Therapeutics Inc has had a low of $0.18 and a high of $2.96. As of last week, the company has a debt-to-equity ratio of 1.05, a current ratio of 0.63, and a quick ratio of 0.63. The fifty day moving average price for VVOS is $0.2669 and a two-hundred day moving average price translates $0.5130 for the stock.
The latest earnings results from Vivos Therapeutics Inc (NASDAQ: VVOS) was released for Jun, 2023. According to the Medical Devices Company, earnings per share came in at -$0.18, missing analysts’ expectations of -$0.14 by -0.04. This compares to -$0.33 EPS in the same period last year. The net profit margin was -121.40% and return on equity was -221.35% for VVOS. The company reported revenue of $3.4 million for the quarter, compared to $4.18 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -18.86 percent. For the current quarter, analysts expect VVOS to generate $4.14M in revenue.
